Biotechs big winners in VC rebound
Biotechnology companies are leading a rebound in venture capital investment in the New York metro area, a new survey shows.
Investors put $380 million into 56 companies in the second quarter of this year, for a 63% jump in venture capital investment over the first quarter, according to the MoneyTree Survey by PricewaterhouseCoopers, Thomson Venture Economics and the National Venture Capital Association.